Patient-Centered Clinical Outcome Assessments in Clinical Trials: Role for Assessing Treatment Benefit in Angelman Syndrome. Angelman Syndrome Biomarker and Outcome Measurement Consortium (A-BOM). December 2018

Invited Talk

Service Performed By

Date

  • December 2018

Service or Event Name

  • Angelman Syndrome Biomarker and Outcome Measurement Consortium (A-BOM)